ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1269

Serum Cytokines Associated with Carotid Atherosclerosis in Rheumatoid Arthritis

Inmaculada del Rincon1, Roy W. Haas2, Daniel H. O'Leary3, Joseph F. Polak3, Daniel F. Battafarano4 and Agustin Escalante5, 1Rheumatology, University of Texas Health Science Center at San Antonio, San Antonio, TX, 2Dept. of Medicine-Rheumatology, University of Texas Health Science Center, San Antonio, TX, 3Radiology, Tufts University-Boston Campus, Boston, MA, 4Medicine / MCHE-MDR, Brooke Army Medical Ctr, San Antonio, TX, 5Dept. of Medicine-Rheumatology, University of Texas Health Science Center at San Antonio, San Antonio, TX

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Atherosclerosis, Cardiovascular disease and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects II: Clinical Features & Comorbidity/Cardiovascular Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose:

The mechanism for the increased cardiovascular morbidity and mortality in rheumatoid arthritis (RA) is incompletely understood. In a previous analysis, we found that both the erythrocyte sedimentation rate and the C-reactive protein were associated with the carotid intima-media thickness (IMT) in RA patients, suggesting that systemic inflammation plays a role. Cytokines are important mediators in inflammation and can be measured in the serum.  We examined the association between the serum concentration of cytokines/chemokines and the carotid IMT in patients with RA.

Methods:

We performed a high-resolution carotid ultrasound in patients with RA for measurement of the internal and common carotid IMT, expressed as a composite.  A subset of patients returned for a repeat ultrasound of the common carotid IMT, following a protocol designed to assess change.  A stored sample of patients’ serum at baseline was used to measure 38 cytokines using a multiplex ELISA technique. We used a multivariable stepwise selection process to identify cytokines associated cross-sectionally with the composite carotid IMT, and with rapid progression of the common carotid IMT.

Results: A baseline scan was performed on 1,162 RA patients, 873 of whom were women. The mean composite carotid IMT was 1.040 mm (SD 0.181 mm).  A subset of 566 patients was eligible for a follow-up scan, which we performed in 487 (86%). The mean (SD) common carotid IMT at baseline was 0.571 mm (0.151), and after a 3 year follow-up, the common carotid IMT increased to a mean of 0.621 mm (0.171), an increase of 0.050 mm (0.055), P < 0.001. Among patients in the highest progression quartile, the common carotid IMT increased by 0.119 mm (0.062). The following serum cytokines were independently associated with the cross-sectional composite IMT, adjusted for age and sex: IL-8, 0.047 (0.018, 0.076); soluble IL-2 receptor-alpha, 0.054 (0.020, 0.089); IL1-receptor antagonist, -0.053, -0.087, -0.018); and macrophage-derived chemokine -0.027 (-0.052, -0.001). Values shown are regression coefficients in mm per SD (95%CI).  Few cytokines were associated with rapid progression of the common carotid IMT, with only the IL-12p40 reaching statistical significance with an odds ratio of 1.67 per SD, 95% CI (1.14, 2.29).

Conclusion:

A number of inflammatory cytokines measured in the serum, notably IL-8, were significantly associated with the carotid IMT. However, in contrast with other RA outcomes, the number of cytokines and the strength of their association with the carotid IMT were modest. This may indicate that cytokines and chemokines exert their effect at the level of the vascular wall rather than though the systemic circulation. These findings help clarify the role of inflammation in rheumatoid atherosclerosis.


Disclosure:

I. del Rincon,
None;

R. W. Haas,
None;

D. H. O’Leary,
None;

J. F. Polak,
None;

D. F. Battafarano,
None;

A. Escalante,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/serum-cytokines-associated-with-carotid-atherosclerosis-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology